Activist investor William Ackman has taken a roughly $2 billion stake in Zoetis Inc. and could push the animal-health company to sell itself to a large drug maker such as Valeant Pharmaceuticals International Inc., according to people familiar with the matter. . Mr. Ackman’s Pershing Square Capital Management LP has built a roughly 10% stake in Zoetis with fellow hedge fund Sachem Head Capital Management LP, the people said. Sachem Head is run by Scott Ferguson, a former protégé of Mr. Ackman. 